For specific symptoms, injection site pain was the most common local AEFI, occurring more frequently in Group II (77%) than in Group I/II (61%), although the difference did not reach statistical significance ( p = 0.1).
← all excerpts
Sex, Age, and Previous Herpes Zoster Infection Role on Adverse Events Following Immunization with Adjuvanted Recombinant Vaccine.
1
0.1000
0.1000